|
1
|
Schimmack S, Svejda B, Lawrence B, Kidd M
and Modlin IM: The diversity and commonalities of
gastroenteropancreatic neuroendocrine tumors. Langenbecks Arch
Surg. 396:273–298. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lawrence B, Gustafsson BI, Chan A, Svejda
B, Kidd M and Modlin IM: The epidemiology of gastroenteropancreatic
neuroendocrine tumors. Endocrinol Metab Clin North Am. 401–18.
(vii)2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Modlin IM, Lye KD and Kidd M: A 5-decade
analysis of 13,715 carcinoid tumors. Cancer. 97:934–959. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oberg K and Castellano D: Current
knowledge on diagnosis and staging of neuroendocrine tumors. Cancer
Metastasis Rev. 30(Suppl 1): 3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Auernhammer CJ and Göke B: Therapeutic
strategies for advanced neuroendocrine carcinomas of jejunum/ileum
and pancreatic origin. Gut. 60:1009–1021. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eriksson B New drugs in neuroendocrine
tumors, . Rising of new therapeutic philosophies? Curr Opin Oncol.
22:381–386. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cho CS, Labow DM, Tang L, Klimstra DS,
Loeffler AG, Leverson GE, Fong Y, Jarnagin WR, D'Angelica MI, Weber
SM, et al: Histologic grade is correlated with outcome after
resection of hepatic neuroendocrine neoplasms. Cancer. 113:126–134.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nikou GC, Lygidakis NJ, Toubanakis C,
Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E and
Safioleas M: Current diagnosis and treatment of gastrointestinal
carcinoids in a series of 101 patients: The significance of serum
chromogranin-A, somatostatin receptor scintigraphy and somatostatin
analogues. Hepatogastroenterology. 52:731–741. 2005.PubMed/NCBI
|
|
9
|
Mazzaferro V, Pulvirenti A and Coppa J:
Neuroendocrine tumors metastatic to the liver: How to select
patients for liver transplantation? J Hepatol. 47:460–466. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Norton JA: Endocrine tumours of the
gastrointestinal tract. Surgical treatment of neuroendocrine
metastases. Best Pract Res Clin Gastroenterol. 19:577–583. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hellman P, Lundström T, Ohrvall U,
Eriksson B, Skogseid B, Oberg K, Janson E Tiensuu and Akerström G:
Effect of surgery on the outcome of midgut carcinoid disease with
lymph node and liver metastases. World J Surg. 26:991–997. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Janson ET, Holmberg L, Stridsberg M,
Eriksson B, Theodorsson E, Wilander E and Oberg K: Carcinoid
tumors: Analysis of prognostic factors and survival in 301 patients
from a referral center. Ann Oncol. 8:685–690. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nykjaer KM, Grønbaek H, Nielsen DT,
Christiansen P and Astrup LB: Description of patients with midgut
carcinoid tumours: Clinical database from a Danish centre. In Vivo.
21:679–684. 2007.PubMed/NCBI
|
|
14
|
Modlin IM, Oberg K, Chung DC, Jensen RT,
de Herder WW, Thakker RV, Caplin M, Fave G Delle, Kaltsas GA,
Krenning EP, et al: Gastroenteropancreatic neuroendocrine tumours.
Lancet Oncol. 9:61–72. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gomez D, Malik HZ, Al-Mukthar A, Menon KV,
Toogood GJ, Lodge JP and Prasad KR: Hepatic resection for
metastatic gastrointestinal and pancreatic neuroendocrine tumours:
Outcome and prognostic predictors. HPB (Oxford). 9:345–351. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Frilling A, Sotiropoulos GC, Li J,
Kornasiewicz O and Plöckinger U: Multimodal management of
neuroendocrine liver metastases. HPB (Oxford). 12:361–379. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Landry CS, Scoggins CR, McMasters KM and
Martin RC: Management of hepatic metastasis of gastrointestinal
carcinoid tumors. J Surg Oncol. 97:253–258. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Musunuru S, Chen H, Rajpal S, Stephani N,
McDermott JC, Holen K, Rikkers LF and Weber SM: Metastatic
neuroendocrine hepatic tumors: Resection improves survival. Arch
Surg. 141:1000–1004; discussion 1005. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Turaga KK and Kvols LK: Recent progress in
the understanding, diagnosis, and treatment of
gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin.
61:113–132. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klimstra DS, Modlin IR, Coppola D, Lloyd
RV and Suster S: The pathologic classification of neuroendocrine
tumors: A review of nomenclature, grading, and staging systems.
Pancreas. 39:707–712. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Soga J: The term ‘carcinoid’ is a
misnomer: The evidence based on local invasion. J Exp Clin Cancer
Res. 28:152009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rorstad O: Prognostic indicators for
carcinoid neuroendocrine tumors of the gastrointestinal tract. J
Surg Oncol. 89:151–160. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sarmiento JM, Heywood G, Rubin J, Ilstrup
DM, Nagorney DM and Que FG: Surgical treatment of neuroendocrine
metastases to the liver: A plea for resection to increase survival.
J Am Coll Surg. 197:29–37. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Norton JA, Warren RS, Kelly MG, Zuraek MB
and Jensen RT: Aggressive surgery for metastatic liver
neuroendocrine tumors. Surgery. 134:1057–1063; discussion
1063–1065. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chamberlain RS, Canes D, Brown KT, Saltz
L, Jarnagin W, Fong Y and Blumgart LH: Hepatic neuroendocrine
metastases: Does intervention alter outcomes? J Am Coll Surg. 190.
432–445. 2000.
|
|
26
|
Adani GL, Baccarani U, Risaliti A,
Sainz-Barriga M, Lorenzin D and Bresadola F: Right lobe living
related graft loss due to intrahepatic multiple arterio-portal
fistulas. Transplant Proc. 36:2733–2735. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Strosberg JR, Cheema A and Kvols LK: A
review of systemic and liver-directed therapies for metastatic
neuroendocrine tumors of the gastroenteropancreatic tract. Cancer
Control. 18:127–137. 2011.PubMed/NCBI
|
|
28
|
Srirajaskanthan R, Toumpanakis C, Meyer T
and Caplin ME: Review article: Future therapies for management of
metastatic gastroenteropancreatic neuroendocrine tumours. Aliment
Pharmacol Ther. 29:1143–1154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bacchetti S, Bertozzi S, Londero AP, Uzzau
A and Pasqual EM: Surgical treatment and survival in patients with
liver metastases from neuroendocrine tumors: A meta-analysis of
observational studies. Int J Hepatol. 2013:2350402013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saxena A, Chua TC, Sarkar A, Chu F, Liauw
W, Zhao J and Morris DL: Progression and survival results after
radical hepatic metastasectomy of indolent advanced neuroendocrine
neoplasms (NENs) supports an aggressive surgical approach. Surgery.
149:209–220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bonaccorsi-Riani E, Apestegui C,
Jouret-Mourin A, Sempoux C, Goffette P, Ciccarelli O, Borbath I,
Hubert C, Gigot JF, Hassoun Z and Lerut J: Liver transplantation
and neuroendocrine tumors: Lessons from a single centre experience
and from the literature review. Transpl Int. 23:668–678. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sutton R, Doran HE, Williams EMI, Vora J,
Vinjamuri S, Evans J, Campbell F, Raraty MG, Ghaneh P, Hartley M,
et al: Surgery for midgut carcinoid. Endocr Relat Cancer.
10:469–481. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Glazer ES, Tseng JF, Al-Refaie W,
Solorzano CC, Liu P, Willborn KA, Abdalla EK, Vauthey JN and Curley
SA: Long-term survival after surgical management of neuroendocrine
hepatic metastases. HPB (Oxford). 12:427–433. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Frilling A, Rogiers X, Malagó M, Liedke
OM, Kaun M and Broelsch CE: Treatment of liver metastases in
patients with neuroendocrine tumors. Langenbecks Arch Surg.
383:62–70. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Coppa J, Pulvirenti A, Schiavo M, Romito
R, Collini P, Di Bartolomeo M, Fabbri A, Regalia E and Mazzaferro
V: Resection versus transplantation for liver metastases from
neuroendocrine tumors. Transplant Proc. 33:1537–1539. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jaeck D, Oussoultzoglou E, Bachellier P,
Lemarque P, Weber JC, Nakano H and Wolf P: Hepatic metastases of
gastroenteropancreatic neuroendocrine tumors: Safe hepatic surgery.
World J Surg. 25:689–692. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mayo SC, de Jong MC, Pulitano C, Clary BM,
Reddy SK, Gamblin TC, Celinksi SA, Kooby DA, Staley CA, Stokes JB,
et al: Surgical management of hepatic neuroendocrine tumor
metastasis: Results from an international multi-institutional
analysis. Ann Surg Oncol. 17:3129–3136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yao KA, Talamonti MS, Nemcek A, Angelos P,
Chrisman H, Skarda J, Benson AB, Rao S and Joehl RJ: Indications
and results of liver resection and hepatic chemoembolization for
metastatic gastrointestinal neuroendocrine tumors. Surgery.
130:677–682; discussion 682–685. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nave H, Mössinger E, Feist H, Lang H and
Raab H: Surgery as primary treatment in patients with liver
metastases from carcinoid tumors: A retrospective, unicentric study
over 13 years. Surgery. 129:170–175. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Le Treut YP, Grégoire E, Klempnauer J,
Belghiti J, Jouve E, Lerut J, Castaing D, Soubrane O, Boillot O,
Mantion G, et al: Liver transplantation for neuroendocrine tumors
in Europe-results and trends in patient selection: A 213-case
European liver transplant registry study. Ann Surg. 257:807–815.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gedaly R, Daily MF, Davenport D, McHugh
PP, Koch A, Angulo P and Hundley JC: Liver transplantation for the
treatment of liver metastases from neuroendocrine tumors: An
analysis of the UNOS database. Arch Surg. 146:953–958. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sartori P, Mussi C, Angelini C, Crippa S,
Caprotti R and Uggeri F: Palliative management strategies of
advanced gastrointestinal carcinoid neoplasms. Langenbecks Arch
Surg. 390:391–396. 2005. View Article : Google Scholar : PubMed/NCBI
|
